<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">8610640</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">104</journal-id>
      <journal-id journal-id-type="nlm-ta">J Bone Miner Res</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Bone Miner. Res.</journal-id>
      <journal-title-group>
        <journal-title>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0884-0431</issn>
      <issn pub-type="epub">1523-4681</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25428889</article-id>
      <article-id pub-id-type="pmc">4406354</article-id>
      <article-id pub-id-type="doi">10.1002/jbmr.2420</article-id>
      <article-id pub-id-type="manuscript">NIHMS681008</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification<sup><xref ref-type="fn" rid="FN3">†</xref></sup></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sheen</surname>
            <given-names>Campbell R.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuss</surname>
            <given-names>Pia</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Narisawa</surname>
            <given-names>Sonoko</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yadav</surname>
            <given-names>Manisha C.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nigro</surname>
            <given-names>Jessica</given-names>
          </name>
          <degrees>B.S.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Wei</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chhea</surname>
            <given-names>T. Nicole</given-names>
          </name>
          <degrees>B.S.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sergienko</surname>
            <given-names>Eduard A.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kapoor</surname>
            <given-names>Kapil</given-names>
          </name>
          <degrees>M.D., Ph.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jackson</surname>
            <given-names>Michael R.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hoylaerts</surname>
            <given-names>Marc. F.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinkerton</surname>
            <given-names>Anthony B.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>O'Neill</surname>
            <given-names>W. Charles</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Millán</surname>
            <given-names>Jose Luis</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Sanford Children's Health Research Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037</aff>
      <aff id="A2"><label>2</label>Cardiometabolic Phenotyping Core, Sanford-Burnham Medical Research Institute at Lake Nona, Orlando, FL 32827</aff>
      <aff id="A3"><label>3</label>Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037</aff>
      <aff id="A4"><label>4</label>Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium</aff>
      <aff id="A5"><label>5</label>Renal Division, Emory University School of Medicine, Atlanta, GA 30322</aff>
      <author-notes>
        <corresp id="FN1">Correspondence Address: José Luis Millán, Ph.D., Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037. Tel: +1-858-646-3130; Fax: +1-858-795-5381; <email>millan@sanfordburnham.org</email></corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>16</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>01</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <volume>30</volume>
      <issue>5</issue>
      <fpage>824</fpage>
      <lpage>836</lpage>
      <!--elocation-id from pubmed: 10.1002/jbmr.2420-->
      <abstract>
        <p id="P1">Medial vascular calcification (MVC) is a pathological phenomenon common to a variety of conditions, including aging, chronic kidney disease, diabetes, obesity, and a variety of rare genetic diseases, that causes vascular stiffening and can lead to heart failure. These conditions share the common feature of tissue-nonspecific alkaline phosphatase (TNAP) upregulation in the vasculature. To evaluate the role of TNAP in MVC, we developed a mouse model that overexpresses human TNAP in vascular smooth muscle cells in an X-linked manner. Hemizygous overexpressor male mice (<italic>Tagln-Cre</italic><sup>+/-</sup>; <italic>Hprt</italic><sup><italic>ALPL</italic>/Y</sup>, or TNAP-OE) show extensive vascular calcification, high blood pressure, cardiac hypertrophy and have a median age of death of 44 days, whereas the cardiovascular phenotype is much less pronounced and life expectancy is longer in heterozygous (<italic>Tagln-Cre</italic><sup>+/-</sup>; <italic>Hprt</italic><sup><italic>ALPL</italic>/-</sup>) female TNAP-OE mice. Gene expression analysis showed upregulation of osteoblast and chondrocyte markers and decreased expression of vascular smooth muscle markers in the aortas of TNAP-OE mice. Through medicinal chemistry efforts, we developed inhibitors of TNAP with drug-like pharmacokinetic characteristics. TNAP-OE mice were treated with the prototypical TNAP inhibitor SBI-425 or vehicle to evaluate the feasibility of TNAP inhibition <italic>in vivo</italic>. Treatment with this inhibitor significantly reduced aortic calcification and cardiac hypertrophy, and extended lifespan over vehicle-treated controls, in the absence of secondary effects on the skeleton. This study shows that TNAP in the vasculature contributes to the pathology of MVC and that it is a druggable target. This article is protected by copyright. All rights reserved</p>
      </abstract>
      <kwd-group>
        <kwd>genetic animal models</kwd>
        <kwd>preclinical studies</kwd>
        <kwd>matrix mineralization</kwd>
        <kwd>therapeutics</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>

